Impact of organized and opportunistic screening on excess mortality and on social inequalities in breast cancer survival
International Journal of Cancer · 2025
DOI: 10.1002/ijc.35173 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, 2025. Verfasst von Marie Poiseuil und 7 weiteren Autor:innen. Beteiligte Einrichtung: Université Bordeaux, Gironde General Cancer Registry, Bordeaux, France. Hauptthemen laut MEDLINE: Breast Neoplasms, Early Detection of Cancer, Socioeconomic Factors. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Institut National du Cancer (INCa), Santé Publique France (SpF).
Abstract (Originalsprache)
In most developed countries, both organized screening (OrgS) and opportunistic screening (OppS) coexist. The literature has extensively covered the impact of organized screening on women's survival after breast cancer. However, the impact of opportunistic screening has been less frequently described due to the challenge of identifying the target population. The aim of this study was to describe the net survival and excess mortality hazard (EMH) in each screening group (OrgS, OppS, or No screening) and to determine whether there is an identical social gradient in each groups. Three data sources (cancer registry, screening coordination centers, and National Health Data System [NHDS]) were used to identify the three screening groups. The European Deprivation Index (EDI) defined the level of deprivation. We modeled excess breast cancer mortality hazard and net survival using penalized flexible models. We observed a higher EMH for “No screening” women compared with the other two groups, regardless of level of deprivation and age at diagnosis. A social gradient appeared for each group at different follow‐up times and particularly between 2 and 3 years of follow‐up for “OrgS” and “OppS” women. Net survival was higher for “OrgS” women than “OppS” women, especially for the oldest women, and regardless of the deprivation level. This study provides new evidence of the impact of OrgS on net survival and excess mortality hazard after breast cancer, compared with opportunistic screening or no screening, and tends to show that OrgS attenuates the social gradient effect.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Université Bordeaux, Gironde General Cancer Registry, Bordeaux, France.
- Inserm, Bordeaux Population Health, Research Center U1219, Team EPICENE, Bordeaux, France.
- Loire-Atlantique/Vendée Cancer Registry, Nantes, France.
- CERPOP, Université de Toulouse, Toulouse, France.
- FRANCIM Network of French Cancer Registries, Toulouse, France.
- Breast and Gynaecologic Cancer Registry of Côte d'Or, Georges Francois Leclerc Comprehensive Cancer Centre, INSERM U1231, 1 rue Professeur Marion, Dijon, France.
ORCID-Profile: Marie Poiseuil, Tienhan Sandrine Dabakuyo-Yonli, Brice Amadeo
Förderung
- Institut National du Cancer (INCa)
- Santé Publique France (SpF)
Zitieren
APA
Poiseuil, M., Molinié, F., Dabakuyo-Yonli, T. S., Laville, I., Fauvernier, M., Remontet, L., Amadeo, B., & Coureau, G. (2025). Impact of organized and opportunistic screening on excess mortality and on social inequalities in breast cancer survival. International Journal of Cancer. https://doi.org/10.1002/ijc.35173
Vancouver
Poiseuil M, Molinié F, Dabakuyo-Yonli TS, Laville I, Fauvernier M, Remontet L, et al. Impact of organized and opportunistic screening on excess mortality and on social inequalities in breast cancer survival. International Journal of Cancer. 2025. doi:10.1002/ijc.35173
BibTeX
@article{Poiseuil2025,
author = {Poiseuil, Marie and Molinié, Florence and Dabakuyo-Yonli, Tienhan Sandrine and Laville, Isabelle and Fauvernier, Mathieu and Remontet, Laurent and Amadeo, Brice and Coureau, Gaëlle},
title = {Impact of organized and opportunistic screening on excess mortality and on social inequalities in breast cancer survival},
journal = {International Journal of Cancer},
year = {2025},
doi = {10.1002/ijc.35173}
}
EUVIMED